Asia Pacific Dry Eye Product Market Drivers and Forecasts by 2027

The Asia Pacific dry eye product market is expected to reach US$ 1786.15 million by 2027 from US$ 1200.95 million in 2019. The market is estimated to grow with a CAGR of 5.3 % from 2019 to 2027.

The Asia Pacific Dry eye Product market is expected to grow owing to the rising incidences of dry eye and increasing geriatric population across the Asia Pacific region. Whereas, major occurrence and the consequence of the side effects is expected to hinder the growth of the Asia Pacific Dry eye Product market during the forecast period.

Dry eye is a chronic syndrome that develops progressively and gets severe with time. It is a condition when a person has scarcity of tears to lubricate his or her eyes. Tears are an essential part of eyes for maintaining good health of the eye and helps in providing good and clear vision. The syndrome is commonly seen among geriatric population and is becoming common among people spending long hours in front of the computer and mobile screens. The reasons that cause dry eye include age, medications, environmental conditions, long term use of contact lenses and accessories. The conditions cannot be cured completely; however, it can be managed by using medical products.

The incidence of dry eye is commonly seen in older people of age 65 and above. The number of geriatric population is increasing rapidly across the world.  Various healthcare companies design their products by focusing on geriatric population. As the degeneration process among older people is much faster, they are highly prevalent to dry eye conditions. Therefore, the high prevalence of dry eye among older population is likely to promote manufacturers to introduce new dry eye products in the market, which, in turn, contributes to the growth of the market.

The development in the healthcare industry has enabled to offer various hi tech healthcare facilities that have allowed offering increased life expectancy. Countries across the world are adopting new techniques to treat older people safely and effectively.

The Asia Pacific region is a highly affected region in the world as the outbreak of COVID–19 has come from China. Countries such as China, India, and South Korea have registered the highest number of COVID–19 positive patients. The countries have imposed lockdowns for several months. Few countries such as South Korea and China have recovered from the pandemic. However, India is still struggling to fight against COVID–19. Therefore, there has been a great economic drop in the country, which is trying to recover. The fast recovery from the situation was seen due to the shift of focus of various companies operating in the ophthalmic division. Companies have shifted their focus towards supplying reliefs to these countries as corporate social responsibility (CSR) activity. Also, governments are seeking help from the private sectors to contribute during the tough situation. Therefore, market players have strengthened their efforts to supply personal protective equipment. For instance, in January 2020, Allergan plc has donated US$ 9,514 million (one million yen) to the Chinese Red Cross Foundation to provide medical masks, robes, gloves, eyewear, and other protective equipment for medical providers in Wuhan.

Asia Pacific Dry Eye Product Market revenue and forecast to 2027

:

Asia Pacific Dry Eye Product MARKET SEGMENTATION

By Product

• Artificial Tears
• Antibiotic drops
• Hormone drops
• Others

By Type

• OTC Drugs
• Prescription Drugs

By Geography

• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia

Company Profiles

• Novartis AG
• Johnson And Johnson Services Inc.
• Santen Pharmaceuticals CO. Ltd
• OASIS Medical
• Abbvie Inc.

Asia Pacific Dry Eye Product Report Scope